| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |